Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Market price (% of par)
-
40.11%
-
Total 13F principal
-
$254,048,851
-
Principal change
-
-$6,584,757
-
Total reported market value
-
$113,326,121
-
Number of holders
-
21
-
Value change
-
-$608,415
-
Number of buys
-
10
-
Number of sells
-
11
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q1 2023
As of 31 Mar 2023,
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by
21 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$254,048,851
in principal (par value) of the bond.
The largest 10 bondholders included
Pentwater Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., DAVIDSON KEMPNER PARTNERS, DAVIDSON KEMPNER CAPITAL MANAGEMENT LP, WHITEBOX ADVISORS LLC, PenderFund Capital Management Ltd., AMERIPRISE FINANCIAL INC, AGF MANAGEMENT LTD, and Affinity Asset Advisors, LLC.
This page lists
21
institutional bondholders reporting positions
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.